FDA Inspection 1172027 — Louisville Reproductive Center

Louisville Reproductive Center — FEI 3005081370

The FDA completed an inspection of Louisville Reproductive Center on June 14, 2022 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 14, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Louisville, KY (United States)